Focus:
Deal News
-
24 June 2019
SCIEX, EluciData agree to address metabolomics research challenges
Life science analytical technologies company SCIEX has announced a co-marketing agreement with disruptive integrated Omics platform company EluciData to address the challenges faced by metabolomics researchers.
-
21 June 2019
Resolution to create biopsy test as companion diagnostic for niraparib
Resolution Bioscience has collaborated with Janssen Research & Development to develop the Resolution HRD liquid biopsy assay as a companion diagnostic for PARP inhibitor, niraparib.
-
21 June 2019
Hologic signs deal to buy SuperSonic Imagine
Hologic has entered an exclusive negotiation agreement to acquire France-based innovator in cart-based ultrasound products SuperSonic Imagine.
-
20 June 2019
Glaukos signs agreement to acquire Dose Medical
Ophthalmic medical technology company Glaukos has signed a definitive agreement and plan of merger to acquire Dose Medical.
-
19 June 2019
Cognizant to acquire technology services company Zenith
Cognizant has signed an agreement to acquire Ireland-based Zenith Technologies.
-
14 June 2019
Orchestra BioMed licenses Virtue SEB to Terumo
Orchestra BioMed has entered a deal providing exclusive worldwide development and commercialisation rights for its Virtue Sirolimus-Eluting Balloon (SEB) to Japanese medical devices maker Terumo.
-
13 June 2019
Smith & Nephew to acquire Switzerland’s Atracsys Sarl
UK-based company Smith & Nephew has entered an agreement to buy Swiss optical tracking technology maker Atracsys Sarl for an undisclosed amount.
-
12 June 2019
Thermo Fisher agrees to terminate $925m Gatan acquisition
Thermo Fisher Scientific has agreed to abandon the proposed acquisition of Gatan from software developer Roper Technologies for approximately $925m.
-
12 June 2019
Boston Scientific completes Vertiflex acquisition for $465m
Boston Scientific has closed the acquisition of spine solutions maker Vertiflex for an upfront cash payment of $465m.
-
7 June 2019
Qiagen and DiaSorin to develop test for Lyme disease
Qiagen and DiaSorin have partnered for the development of an ultra-sensitive QuantiFERON-based diagnostic test to detect Lyme disease early.
Close
Close
Close
Go Top
